Navigation Links
Interim results of VITOBA™ (VImpaT® added to One Baseline AED) Study Presented at the 64th Annual Meeting of the American Academy of Neurology
Date:4/26/2012

d treatment setting and suggests the effect of adding Vimpat® as an adjunctive therapy after initial monotherapy. These results need to be confirmed by the final analysis when the study concludes," said Matthias Noack-Rink, lead study author and Medical Affairs Director, Epilepsy, UCB Germany.

Vimpat® is indicated as an adjunctive therapy for the treatment of partial-onset seizures in adults with epilepsy.  The most common adverse reactions reported in pivotal trials and occurring in 10 percent or more of lacosamide-treated patients, and greater than placebo, were dizziness, headache, nausea and diplopia.  Additional important safety information for Vimpat® is available at the end of the press release.

About Epilepsy
Epilepsy is a chronic neurological disorder affecting approximately 50 million people worldwide and 3 million people in the U.S. Anyone can develop epilepsy; it occurs across all ages, races and genders.  Uncontrolled seizures and medication side effects pose challenges to independent living, learning and employment, so the goal of epilepsy treatment is seizure freedom with minimal side effects.  More than 1 million patients in the U.S. continue to have seizures despite initial therapy, and more than 800,000 patients in the U.S. continue to have seizures despite treatment with two or more therapies. [1],[2]

About Vimpat
Vimpat® tablets and injection were launched in the US in May 2009 as an add-on therapy for the treatment of partial-onset seizures in people with epilepsy who are aged 17 years and older.  Vimpat® injection is a short-term replacement when oral administration is not feasible in these patients.  Vimpat® oral solution was launched in June 2010.  The availability of the oral tablets, oral solution, and IV injection allows for consistent treatment in a hospital setting.  The most common adverse reactions occurring in gr
'/>"/>

SOURCE UCB
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
2. Interim Response and Safety Analyses Support Continuation of Allos Therapeutics Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-Cell Lymphoma
3. Immtech Announces Interim Analysis in Phase III African Sleeping Sickness Trial
4. Interim Safety Data Favorable for Vicals Phase 2 Trial of DNA Vaccine Against CMV
5. Interim Phase 2 Data for Exelixis XL880 Show Anti-Tumor Activity in Papillary Renal Cell Cancer
6. Leading Physicians Present Interim Results from Multi-Center Studies of VNUS ClosureFAST Catheter at VEITHsymposium
7. Grantees of the Avon Foundation Breast Cancer Prevention Research Initiative Gather in Houston to Report Interim Findings
8. Novavax Announces Favorable Interim Results from Human Clinical Trial for Its Pandemic Influenza Vaccine Program
9. Interim Safety Analysis Supports Continuation of Allos Therapeutics Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-cell Lymphoma
10. Interim Analysis Supports Continuation of Cell Genesys VITAL-1 Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer
11. NanoBio Corporation Presents Preclinical and Interim Clinical Data on Topical Treatments for Herpes Labialis and Onychomycosis at AAD 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... , Dec. 17, 2014  IGI Laboratories, Inc. ... the closing of its offering of $125 million aggregate ... (the "Notes").  The Notes were offered and sold only ... the Securities Act of 1933, as amended (the "Securities ... fixed rate of 3.75% per year, payable semiannually in ...
(Date:12/15/2014)... Dec. 12, 2014 Research and Markets ... of the "MEMS Gyroscopes Analog Devices ADIS16136 ... report to their offering. ... tactical grade applications made a lot of progress ... reliability. They are now accepted in high-reliability environments, ...
(Date:12/15/2014)... and HERZLIYA PITUACH, Israel , Dec. ... IMNP ) announced today that its Board of ... succeeding Dr. Daniel Teper who continues as Chief ... of Immune,s Board of Directors since 2013. Immune,s ... delighted to represent the interest of shareholders and to continue ...
Breaking Medicine Technology:IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 2IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 3IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 4MEMS Gyroscopes Analog Devices ADIS16136 Precision Angular Rate Sensor Reverse Costing Analysis 2Immune Pharmaceuticals Elects Daniel Kazado as New Chairman of the Board. 2Immune Pharmaceuticals Elects Daniel Kazado as New Chairman of the Board. 3Immune Pharmaceuticals Elects Daniel Kazado as New Chairman of the Board. 4
... Retirement Living TV (RLTV), the only network dedicated to ... Body Health on Thursday, November 19(th) at 8:00 pm ... to the center of public policy, award-winning medical journalist Kevin ... and advice tied to complementary and integrative medicine. He ...
... , WOODCLIFF LAKE, N.J., Nov. 16 Par Pharmaceutical ... Day from 9:00am to 12:00pm EST on December 3, 2009 at ... Executive Officer, Patrick G. LePore, and other members of the senior ... current products and pipelines, and business outlook to analysts and investors. ...
Cached Medicine Technology:Retirement Living TV Premieres Season Two of Whole Body Health 2
(Date:12/17/2014)... -- Expectant parents should leave prenatal picture-taking to medical ... Use of ultrasound imaging and heartbeat monitors to get ... agency warns. "Although there is a lack ... and heartbeat monitors, prudent use of these devices by ... FDA biomedical engineer, said in an agency news release. ...
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. 16, ... America, and work commitment is a big reason why, new ... said Dr. Mathias Basner, an assistant professor of sleep and ... of Medicine. A time-use survey of nearly 125,000 Americans, ... main activity exchanged for sleep. Short sleepers -- those who ...
(Date:12/15/2014)... 15, 2014 South Florida’s leading urgent care ... can be a daze of hassle, hustle, and bustle that ... decking halls, to burns when making special meals and heartburn ... can happen at any time. To prevent this season of ... made a list of helpful and healthful holiday tips to ...
(Date:12/15/2014)... News) -- Expert pilots process visual information more efficiently ... better decisions during landings, a new study shows. ... pilots to master, and 36 percent of all airplane ... final approach and landing. Researchers monitored the brain ... pilots while they were at the controls of a ...
(Date:12/15/2014)... 15, 2014 At the leading, long-established ... AutismOne and Focus Autism will welcome ... research on the effects of toxins to children’s health, ... information. , Luminaries such as Dr. Lucija Tomljenovic ... with esteemed, credentialed colleagues of the United States to ...
Breaking Medicine News(10 mins):Health News:FDA Warns Against Fetal 'Keepsake' Videos 2Health News:Work Steals Valuable Sleep Time, Study Finds 2Health News:Work Steals Valuable Sleep Time, Study Finds 3Health News:MD Now Urgent Care Presents Healthy Holiday Tips 2Health News:MD Now Urgent Care Presents Healthy Holiday Tips 3Health News:Study Shows Why Expert Pilots Are Experts 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 3
... Need for continuing, open dialogue remains , ... While health care reform legislation currently in Congress addresses many of the ... a number of issues including the public health insurance option and the ... "It is our objective to be a constructive partner with Congress and ...
... ... 1 August 2009 all doctors in training should be working a 48-hour week. Aimed at ... leaders are also seeing this move as a great opportunity, writes Robert Stiff MD Team24. ... (PRWeb UK) July ...
... , , , ... Inc. (PSH), a Los Angeles-based manufacturing and distribution corporation is proud to ... balm product division. Burner Balm, a natural lip balm that claims ... dietary, energy drink and lip balm arena. The product line is turning ...
... the heart , WEDNESDAY, July 22 (HealthDay News) -- ... one day be able to reverse the electrical problems in ... , Researchers grew "beating" cells with properties similar to the ... fat tissue of mice. They then injected them into rodents ...
... FT. MYERS, Fla., July 22 NeoGenomics, Inc. (NASD OTC ... quarter 2009 financial results on Tuesday, July 28, 2009. , ... call to discuss their Q2 09 results on July 28, 2009, at ... (201) 689-8049 (international) at least five minutes prior to the call. ...
... , AUSTIN, Texas, July 22 There are 125,000 ... solutions are the 125,000 NPs practicing in the United States today. For ... specialty care needs of their patients with the highest level of ... care provider, just as others may select MDs or DOs. , ...
Cached Medicine News:Health News:Michigan State Medical Society Weighs in on Proposed Federal Health Care Reform Legislation 2Health News:Team24 News Article - New EU Directive Offers a Healthy Outlook for Niche Recruitment Companies like Team24 2Health News:Team24 News Article - New EU Directive Offers a Healthy Outlook for Niche Recruitment Companies like Team24 3Health News:Burner Balm Gets International Attention 2Health News:Stem Cells Used for 'Biological Pacemaker' 2Health News:NeoGenomics Schedules Its Q2 2009 Earnings Release for July 28, 2009 2Health News:125,000 Solutions to the Primary Care Shortage - Nurse Practitioners (NPs) 2
Shafts angled 45 degrees, 10 mm from tip to bend. 1 x 2 teeth. Serrated handle with polished finish. Most popular size or model....
Shafts angled 45 degrees, 10 mm from tip to bend. Tips curved with 0.5 mm, 1 x 2 teeth. Serrated handle with polished finish....
Straight shafts with 5.5 mm tying platform and 1 mm crisscross serrated tips. Wide serrated handle with polished finish....
Smooth pointed tips open to 3.0 mm. Cross action curved shafts. Tip to Angle Length: 12.0 mm. Round handle....
Medicine Products: